Euan Thomson Chair, Oviva

Company

Oviva is Europe’s leading provider of digital, reimbursed chronic care. Since 2014, the company helped nearly 1 million patients in the UK, Germany, and Switzerland make sustainable lifestyle changes. Their certified medical app combines personalized coaching with access to weight-loss medications – fully integrated into public healthcare systems. The business is growing rapidly, up >100% year over year, and is backed by investors including Sofina, Temasek, Albion, MTIP and Earlybird. As the company scales, it sits at the intersection of digital therapeutics, weight management and the evolving GLP-1 treatment landscape.

Search Background

As Oviva prepared for the next phase of its journey, the CEO and Board recognised the need for a Non-Executive Chair who could bring strategic depth, operational experience, and scaling expertise. The incoming Chair would play a key role in supporting the executive team through continued growth, international expansion and potential future funding or exit scenarios.

Requirements

Oviva was looking for someone who had:
• Scaled a healthtech company to $200m+ revenue and 1,000+ employees
• Led or played a critical role in an exit (IPO or strategic acquisition)
• A deep understanding of regulated, tech-enabled healthcare businesses
• The experience and ability to mentor the CEO and support the broader executive team
• Ideally, a strong network across European or US healthtech and investment communities

Result

Erevena ran a global search across Europe and the United States. We mapped all CEOs, Chairs and NEDs of healthtech businesses that had successfully scaled from $50m to $200m+ in revenue, expanded headcount to 1,000 people, and led or supported a successful exit. This included both public and private companies, with a particular focus on digital health, virtual care, medtech and digital therapeutics.

We worked closely with the CEO, Kai Eberhardt, and Oviva’s investors to ensure cultural alignment and clarity on the brief.

Oviva appointed Euan Thomson as Chair of Oviva in 2025.

Euan brings a unique blend of entrepreneurial and corporate leadership experience in healthtech. As CEO of Accuray, he scaled the business from under $10m to over $400m in revenue, grew the team to over 1,000 employees, and led the company through a successful IPO. He subsequently worked with Khosla Ventures to build a healthcare investment portfolio, served as CEO of AliveCor, and held senior digital health roles at Samsung and Johnson & Johnson. Most recently, he was President and CEO of Carl Zeiss Meditec Inc and Head of the Global Digital Business Unit at ZEISS Medical Technology.

Euan’s background in clinical innovation, digital health strategy and global leadership made him an ideal fit for Oviva’s next chapter.

One of the key lessons from this search was the importance of maintaining momentum and keeping the group of decision-makers tight. By working closely with the CEO and a small, empowered group from the Board, you can iterate quickly, give real-time feedback to candidates and avoid long delays caused by coordinating multiple diaries. In fast-moving markets like healthtech, speed and clarity can make a real difference in securing top talent.